Pulmonary diseases such as pneumonia, tuberculosis, pulmonary edema, interstitial lung disease, and lung cancer remain major contributors to global morbidity and mortality. Chest X-ray (CXR) imaging continues to be the most frequently employed diagnostic modality for initial evaluation of suspected lung pathology due to its wide availability, low cost, rapid acquisition, and relatively low radiation dose [1]. Detection and interpretation of lung opacities on CXRs play a central role in clinical decision-making, disease staging, and treatment monitoring. Despite its clinical importance, conventional interpretation of lung opacities on chest radiographs is largely qualitative and dependent on the experience of the radiologist. This subjectivity leads to considerable inter-observer variability, particularly in cases with subtle, diffuse, or overlapping radiographic findings [2]. Variations in image quality, patient positioning, and anatomical superimposition further complicate accurate assessment, potentially resulting in delayed diagnosis or inconsistent severity grading [3]. Recent advances in computer-aided diagnosis (CAD) and artificial intelligence (AI) have introduced quantitative approaches to chest radiograph analysis. These methods enable objective measurement of lung opacity extent, density, and spatial distribution, thereby reducing observer-dependent bias and improving reproducibility [4]. Quantitative lung opacity analysis has shown particular value in disease severity assessment, longitudinal monitoring, and evaluation of treatment response, especially in settings where advanced imaging modalities such as computed tomography (CT) are not readily accessible [5]. Chest X-ray remains indispensable in emergency departments, outpatient clinics, and intensive care units, where rapid decision-making is critical [6]. However, the limitations of purely visual assessment have prompted growing interest in automated image analysis techniques. Deep learning-based models have demonstrated promising performance in detecting and quantifying lung opacities associated with pneumonia, tuberculosis, interstitial lung disease, and viral infections, including COVID-19 [7,8]. During the COVID-19 pandemic, AI-assisted CXR analysis proved valuable for severity stratification, triage, and outcome prediction, highlighting the clinical relevance of quantitative imaging tools [9]. Lung opacities represent regions of increased pulmonary density on chest radiographs and may arise from infectious, inflammatory, neoplastic, or vascular processes. Radiographically, these opacities manifest in diverse patterns such as alveolar consolidation, interstitial thickening, nodular lesions, ground-glass opacities, and reticular or honeycomb patterns, each associated with specific disease processes [10]. Accurate characterization of these patterns is essential for differential diagnosis, yet qualitative interpretation alone often fails to capture subtle differences in extent and severity. Quantitative analysis offers several advantages over traditional qualitative assessment. Automated segmentation and pixel-based density analysis allow precise estimation of the percentage of lung involvement, facilitating standardized severity scoring and enabling meaningful comparisons across patients and time points [11]. Moreover, AI-driven systems can process large volumes of imaging data efficiently, supporting high-throughput clinical workflows and reducing radiologist workload [12]. Despite these advancements, challenges remain, including variability in image acquisition protocols, limited availability of annotated datasets, and concerns regarding generalizability across populations. Nonetheless, ongoing developments in deep learning architectures, federated learning, and multi-institutional training frameworks continue to enhance the robustness of AI-based imaging tools [13]. Given the persistent reliance on chest radiography for pulmonary disease evaluation, particularly in resource-limited settings, there is a pressing need for accurate, objective, and reproducible methods to quantify lung opacities on routine CXRs. Integrating AI-based quantitative analysis into standard radiological practice has the potential to improve diagnostic consistency, support clinical decision-making, and enhance patient outcomes. The present study aims to evaluate AI-based quantitative lung opacity assessment on routine chest X-ray radiographs and examine its diagnostic utility in comparison with conventional radiologist interpretation.
MATERIALS AND METHODS
Study Design and Setting
This study was designed as a prospective cross-sectional observational study conducted in the Department of Radiology at SCPM Hospital, Gonda, Uttar Pradesh, India. The study was carried out over a defined study period after obtaining institutional ethical clearance and written informed consent from all participants.
Study Population
The study population comprised adult patients referred for routine chest X-ray examination with radiographically detectable lung opacities. A total of 80 patients were included using a purposive sampling technique to ensure representation of common pulmonary pathologies.
Inclusion Criteria
- Patients aged 18 years and above
- Presence of lung opacities on routine chest X-ray
- Diagnosed or clinically suspected cases of pneumonia, tuberculosis, pulmonary edema, interstitial lung disease, or lung malignancy
- Patients who provided written informed consent
Exclusion Criteria
- Patients with normal chest X-ray findings
- Chest X-rays with severe motion artifacts or poor image quality unsuitable for analysis
- Patients with prior thoracic surgery or congenital lung abnormalities
- Patients unwilling to participate
Image Acquisition
All chest X-ray images were acquired using a digital radiography system following standard departmental protocols. Posteroanterior (PA) chest radiographs were obtained whenever feasible, with patients positioned erect and instructed to hold breath at full inspiration. Exposure parameters were adjusted according to patient body habitus to ensure optimal image quality. Image quality was later categorized as good, average, or poor based on radiographic clarity and diagnostic adequacy.
AI-Based Lung Opacity Quantification
Digital chest X-ray images were analyzed using computer-aided diagnosis (CAD) software integrated with artificial intelligence algorithms. The AI system performed automated lung field segmentation, separating normal lung parenchyma from pathological regions. Lung opacity extent was calculated as the percentage of lung area involved, based on pixel density and segmentation outputs. An AI opacity score ranging from 0 to 1 was generated for each image, reflecting the severity of lung opacity. Based on predefined thresholds, AI scores were categorized into low, moderate, and high severity groups for comparative analysis.
Radiologist Assessment
All chest X-ray images were independently reviewed by qualified radiologists who were blinded to the AI results. Lung opacities were graded visually as low, medium, or high severity based on extent, density, and distribution of opacities. These assessments served as the reference standard for comparison with AI-derived scores.
Clinical Data Collection
Demographic and clinical data were collected using a structured proforma and included:
- Age and gender
- Smoking status
- Clinical diagnosis
- Duration of hospital stay
All patient data were anonymized prior to analysis.
Sample Size Calculation
The sample size was calculated using a standard formula for cross-sectional studies, assuming a 95% confidence level and a margin of error of 10%. Based on feasibility and study duration, a final sample size of 80 patients was included.
Statistical Analysis
Statistical analysis was performed using SPSS software.
- Descriptive statistics (mean, standard deviation, frequency, and percentage) were used to summarize demographic variables, lung opacity extent, AI scores, and hospital stay duration.
- One-way Analysis of Variance (ANOVA) was applied to assess differences in lung opacity extent across different pulmonary diagnoses.
- Chi-square test was used to evaluate the association between AI-based opacity categories and radiologist-assigned opacity grades.
- Pearson correlation analysis was conducted to examine the relationship between lung opacity extent and duration of hospital stay.
- Receiver Operating Characteristic (ROC) curve analysis was performed to assess the diagnostic performance of the AI opacity score in classifying lung opacity severity.
A p-value < 0.05 was considered statistically significant for all analyses.
RESULTS
A total of 80 patients with radiographically detectable lung opacities on routine chest X-ray were included in the analysis. The results are presented under demographic characteristics, radiographic findings, AI-based opacity analysis, and statistical associations.
Table 1. Gender Distribution of Study Participants (N = 80)
|
Gender |
Frequency |
Percentage (%) |
|
Male |
38 |
47.5 |
|
Female |
42 |
52.5 |
|
Total |
80 |
100 |
Interpretation:
The study population showed a nearly equal gender distribution, with a slight predominance of females (52.5%). This balanced distribution reduces gender-related sampling bias and allows reliable comparison of imaging findings.
Table 2. Smoking Status Distribution
|
Smoking Status |
Frequency |
Percentage (%) |
|
Smoker |
42 |
52.5 |
|
Non-smoker |
38 |
47.5 |
|
Total |
80 |
100 |
Interpretation:
More than half of the participants were smokers (52.5%), which is clinically relevant given the known association between smoking and chronic lung pathologies, malignancy, and interstitial lung disease.
Table 3. Frequency Distribution of Diagnoses
|
Diagnosis |
Frequency |
Percentage (%) |
|
Tuberculosis |
20 |
25.0 |
|
Pneumonia |
18 |
22.5 |
|
Interstitial Lung Disease |
14 |
17.5 |
|
Lung Cancer |
14 |
17.5 |
|
Pulmonary Edema |
14 |
17.5 |
|
Total |
80 |
100 |
Interpretation:
Tuberculosis was the most common diagnosis (25%), followed by pneumonia (22.5%). This distribution reflects the high burden of infectious lung diseases in routine clinical practice, especially in resource-limited settings.
Table 4. Distribution of Lung Opacity Severity (AI-Based)
|
Opacity Severity |
Frequency |
Percentage (%) |
|
Mild |
28 |
35.0 |
|
Moderate |
22 |
27.5 |
|
Severe |
30 |
37.5 |
|
Total |
80 |
100 |
Interpretation:
Severe lung opacities were observed in 37.5% of patients, indicating that a substantial proportion presented with advanced radiographic involvement at the time of imaging.
Table 5. Radiologist Opacity Grading
|
Opacity Grade |
Frequency |
Percentage (%) |
|
Low |
30 |
37.5 |
|
Medium |
25 |
31.3 |
|
High |
25 |
31.3 |
|
Total |
80 |
100 |
Interpretation:
Radiologist grading showed the highest proportion of cases classified as low severity (37.5%). Distribution across grades highlights subjective variation in visual assessment.
Table 6. Image Quality Assessment
|
Image Quality |
Frequency |
Percentage (%) |
|
Good |
30 |
37.5 |
|
Average |
23 |
28.7 |
|
Poor |
27 |
33.8 |
|
Total |
80 |
100 |
Interpretation:
Only 37.5% of CXRs were graded as good quality, emphasizing the importance of AI-based analysis that can function reliably even with suboptimal imaging conditions.
Table 7. Descriptive Statistics
|
Variable |
Mean ± SD |
Minimum |
Maximum |
|
Age (years) |
46.34 ± 17.74 |
20 |
79 |
|
Lung Opacity Extent (%) |
Pankaj Kumar*
Sandhya Verma
Shubhanshi Rani
Jyoti Yadav
Shivam Sing
10.5281/zenodo.18220096